04 Malignant Skin Lesions

Httpwwwskincarephysicianscommelanomanet accessed june

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: armon MB, Murray T, et al: Cancer statistics 2001. CA Cancer J Clin 51:15, 2001 26. Hashemi J, Linder S, Platz A, et al: Melanoma development in relation to non-functional p16/INK4A protein and dysplastic nevus syndrome in Swedish melanoma kindred. Melanoma Res 9:21, 1999 27. American Academy of Dermatology: Melanoma Net. http://www.skincarephysicians.com/melanomanet, accessed June 2006 patients: validation of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19:3622, 2001 35. Francken AB, Shaw HM, Thompson JF, et al: The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11:426, 2004 36. Gimotty PA, Guerry D, Ming ME, et al: Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 22:3668, 2004 37. Buzaid AC, Tinoco LA, Jendiroba D, et al: Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 13:2361, 1995 38. Johnson TM, Bradford CR, Gruber SB, et al: Staging workup, sentinel node biopsy, and followup tests for melanoma. Arch Dermatol 140:107, 2004 39. Riker AI, Glass F, Perez I, et al: Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatol Ther 18:387, 2005 40. Gershenwald JE, Colome MI, Lee JE, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253, 1998 41. Thompson JF, Uren RF: Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol 6:877, 2005 28. Schwartz JL, Wang TS, Hamilton TA, et al: Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 95:1562, 2002 42. Morton DL, Thompson JF, Nieweg OE: The sentinel lymph node biopsy procedure: identification with blue dye and a gamma probe. Textbook of Melanoma. Thompson JF, Morton DL, Kroon BB, Eds. Martin Dunitz, London, 2004, p 323 29. Friedman RJ, Rigel DS, Silverman MK, et al: Malignant melanoma in the 1990s: the continued importance of early detection and the role of the physician examination and self-examination of the skin. CA Cancer J Clin 41:201, 1991 43. Gershenwald JE, Mansfield PF, Lee JE, et al: Role of lymphatic mapping and sentinel lymph node biopsy in patients with thick (> 4 mm) primary melanoma. Ann Surg Oncol 7:160, 2000 30. Crowson AN, Magro CM, Mihm MC Jr: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 19:S71, 2006 31. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902, 1970 32. Clark WH Jr, From L, Bernardino EA, et al: Histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705, 1969 33. Homsi J, Kashani-Sabet M, Messina JL, et al: Cutaneous melanoma: prognostic...
View Full Document

{[ snackBarMessage ]}

Ask a homework question - tutors are online